Get the Stockscreener App
55.82
4.16%
2.23
Lantheus Holdings Inc stock is traded at $55.82, with a volume of 1.31M.
It is up +4.16% in the last 24 hours and down -3.26% over the past month.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
See More
Previous Close:
$53.59
Open:
$53.44
24h Volume:
1.31M
Relative Volume:
0.94
Market Cap:
$3.70B
Revenue:
$1.50B
Net Income/Loss:
$427.61M
P/E Ratio:
9.2879
EPS:
6.01
Net Cash Flow:
$423.98M
1W Performance:
+5.30%
1M Performance:
-3.26%
6M Performance:
-25.70%
1Y Performance:
-36.07%
1-Day Range:
$53.38
$57.35
1-Week Range:
$51.80
$57.35
52-Week Range:
$47.25
$111.29
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
55.82 | 3.55B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
122.06 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.87 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.21 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.82 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-25 | Downgrade | Goldman | Buy → Neutral |
| Aug-12-25 | Downgrade | Truist | Buy → Hold |
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Barchart.com
How risky is Lantheus Holdings Inc. (0L8) stock compared to peersTrade Ideas & Fast Exit and Entry Strategy Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Stockholders to Reach Out - ACCESS Newswire
Is Lantheus Holdings Inc. stock oversold or undervaluedShare Buyback & AI Powered Market Entry Strategies - newser.com
Is Lantheus Holdings Inc. (0L8) stock a top hedge fund pickMarket Risk Report & Real-Time Volume Analysis - newser.com
Is Lantheus Holdings Inc. (0L8) stock worth holding before Fed meeting2025 Price Targets & Weekly High Momentum Picks - newser.com
Will Lantheus Holdings Inc. stock benefit from automationWeekly Investment Recap & Verified Stock Trade Ideas - newser.com
How Lantheus Holdings Inc. stock valuations compare to rivals2025 Institutional Moves & Accurate Entry/Exit Alerts - newser.com
Is Lantheus Holdings Inc. stock attractive for ETFsJuly 2025 Sentiment & Safe Entry Point Alerts - newser.com
Why Lantheus Holdings Inc. stock is favored by pension fundsExit Point & AI Driven Stock Movement Reports - newser.com
Why retail traders accumulate Lantheus Holdings Inc. (0L8) stockWeekly Gains Report & Weekly Setup with High ROI Potential - newser.com
Live market analysis of Lantheus Holdings Inc.Market Movement Recap & Free Weekly Watchlist of Top Performers - newser.com
Can machine learning forecast Lantheus Holdings Inc. recoveryPortfolio Return Report & High Accuracy Swing Entry Alerts - newser.com
Trading Systems Reacting to (LNTH) Volatility - news.stocktradersdaily.com
Lantheus (LNTH): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Lantheus Holdings, Inc. (LNTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Can Lantheus Holdings Inc. (0L8) stock sustain double digit ROE2025 Year in Review & Risk Managed Investment Entry Signals - newser.com
Can a trend reversal in Lantheus Holdings Inc. lead to recoveryJuly 2025 Selloffs & Safe Entry Point Identification - newser.com
Lantheus Holdings Inc. stock trendline breakdownBuy Signal & Fast Exit/Entry Strategy Plans - newser.com
How Lantheus Holdings Inc. stock compares to market leadersWeekly Market Report & AI Powered Buy and Sell Recommendations - newser.com
Why Lantheus Holdings Inc. stock could outperform in 20252025 Technical Patterns & Risk Adjusted Swing Trade Ideas - newser.com
Allianz SE Sells 7,520 Shares of Lantheus Holdings, Inc. $LNTH - Defense World
Is a relief rally coming for Lantheus Holdings Inc. holdersEarnings Trend Report & High Accuracy Trade Alerts - newser.com
It is Poised to be a Bull Market for Lantheus Holdings Inc (LNTH) - Setenews
5 Insightful Analyst Questions From Lantheus's Q3 Earnings Call - Finviz
Bragar Eagel & Squire is Investigating Certain Officers and - GlobeNewswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Lantheus CEO Brian Markison Announces Retirement - The Globe and Mail
The Bottom Fishing ClubLantheus Holdings: Interesting Buy Momentum Supporting Price (NASDAQ:LNTH) - Seeking Alpha
Lantheus Holdings' (NASDAQ:LNTH) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
What makes Lantheus Holdings Inc. stock attractive to growth funds2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
Lantheus stock price target lowered to $90 at Leerink on 340B pricing impact - Investing.com Canada
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):